Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.
AUTOR(ES)
Gelber, R H
RESUMO
Model vaccines against leprosy bacilli have consisted of nonvirulent, live, attenuated Mycobacterium bovis BCG and irradiated, heat-killed, or autoclaved intact M. leprae. We report that immunization with various cell wall fractions of M. leprae, progressively depleted of lipids, carbohydrates, and soluble proteins, as well as a partially purified protein(s) derived from a pellet fraction of sonicated M. leprae, conferred significant protection against subsequent infection with live leprosy bacilli. Moreover, lymphocytes from regional lymph nodes and spleens of mice immunized with these M. leprae-derived subunits responded by proliferation when stimulated with M. leprae in vitro. Our results provide the first evidence that vaccination with M. leprae-derived fractions protects mice against leprosy bacilli.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=258523Documentos Relacionados
- Vaccination of mice against Mycobacterium leprae infection.
- Superinfection in mice previously infected with Mycobacterium leprae.
- Human monoclonal antibodies against Mycobacterium leprae.
- Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
- Effective, Nonsensitizing Vaccination with Culture Filtrate Proteins against Virulent Mycobacterium bovis Infections in Mice
